Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.

Zhang Z, Wang Y, Lantry LE, Kastens E, Liu G, Hamilton AD, Sebti SM, Lubet RA, You M.

Oncogene. 2003 Sep 18;22(40):6257-65.

PMID:
13679864

Supplemental Content

Loading ...
Support Center